Efficacy and safety of milk thistle preventive treatment of anti-tuberculosis drug-induced liver injury A protocol for systematic review and meta-analysis

被引:4
|
作者
Shi, Zhipeng [1 ]
Wu, Jing [1 ]
Yang, Qiang [1 ]
Xia, Hong [1 ]
Deng, Min [1 ]
Yang, Yuxia [1 ]
机构
[1] Peoples Hosp Dazu Dist Chongqing, Chongqing, Peoples R China
关键词
anti-tuberculosis drug-induced liver injury; milk thistle; preventive treatment; protocol; system evaluation; MECHANISM;
D O I
10.1097/MD.0000000000023674
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Tuberculosis is an infectious disease caused by mycobacterium tuberculosis. It may occur in multiple parts and organs of the patients body, and the lung is the most common. It is a major health threat worldwide. Hepatotoxicity is a common adverse reaction of commonly used clinical anti-tuberculosis drugs, as well as one of the important factors leading to poor prognosis of tuberculosis. Milk thistle is a traditional Chinese medicine extract derived from the mature fruit of Silybum marianum. Clinical practice shows that milk thistle has a good anti-liver injury effect and can be used to prevent anti-tuberculosis drug-induced liver injury. However, there is a lack of evidence-based medicine. The research carried out in this protocol is to systematically evaluate the efficacy and safety of milk thistle preventive treatment of anti-tuberculosis drug-induced liver injury, and to improve the evidence-based basis for clinical application of milk thistle in the preventive treatment of anti-tuberculosis drug-induced liver injury. Method: Computer search of English databases (PubMed, the Cochrane Library, Embase, Web of Science) and Chinese databases (CNKI, VIP, Wanfang, China Biology Medicine disc (CBMdisc)) was performed. From the establishment of database to October 2020, 2 researchers independently extracted and evaluated the data included in the randomized controlled clinical research of milk thistle preventive treatment of anti-tuberculosis drug-induced liver injury, and used RevMan5.3 software to conduct a meta-analysis of the included literature. Result: In this research, the efficacy and safety of milk thistle preventive treatment of anti-tuberculosis drug-induced liver injury were evaluated by indicators such as the incidence of liver injury, bilirubin levels, and liver enzyme levels. Conclusion: In this research, reliable evidence-based evidence for the clinical application of milk thistle in the preventive treatment of anti-tuberculosis drug-induced liver injury was provided.
引用
收藏
页数:5
相关论文
共 50 条
  • [1] The susceptibility of anti-tuberculosis drug-induced liver injury and chronic hepatitis C infection: A systematic review and meta-analysis
    Chang, Tien-En
    Huang, Yi-Shin
    Chang, Chih-Hao
    Perng, Chin-Lin
    Huang, Yi-Hsiang
    Hou, Ming-Chih
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2018, 81 (02) : 111 - 118
  • [2] Drug-metabolising enzyme polymorphisms and predisposition to anti-tuberculosis drug-induced liver injury: a meta-analysis
    Sun, F.
    Chen, Y.
    Xiang, Y.
    Zhan, S.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2008, 12 (09) : 994 - 1002
  • [3] Silymarin in Preventing Anti-Tuberculosis and Antipsychotic Drug-Induced Liver Injury at Different Doses and Treatment Times: A Systematic Review
    Sheng, Ying Kun
    Zhang, Lu
    Hong, Yin
    IRANIAN RED CRESCENT MEDICAL JOURNAL, 2019, 21 (10)
  • [4] Genetic polymorphisms and anti-tuberculosis drug-induced liver injury: an umbrella review of the evidence
    Cheng, Jingru
    Zhu, Jia
    Chen, Ruina
    Zhang, Meiling
    Han, Bing
    Zhu, Min
    He, Yiwen
    Yi, Honggang
    Tang, Shaowen
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2025, : 624 - 639
  • [5] Preventive use of a hepatoprotectant against anti-tuberculosis drug-induced liver injury: A randomized controlled trial
    Zhang, Simin
    Pan, Hongqiu
    Peng, Xianzhen
    Lu, Hui
    Fan, Hong
    Zheng, Xianzhi
    Xu, Guisheng
    Wang, Min
    Wang, Jianming
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 31 (02) : 409 - 416
  • [6] Prophylactic Therapy of Silymarin (Milk Thistle) on Antituberculosis Drug-Induced Liver Injury: A Meta-Analysis of Randomized Controlled Trials
    Tao, Lina
    Qu, Xiaoyu
    Zhang, Yue
    Song, Yanqing
    Zhang, Si-xi
    CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 2019
  • [7] GSTM1 and GSTT1 null polymorphisms and susceptibility to anti-tuberculosis drug-induced liver injury: a meta-analysis
    Tang, N.
    Deng, R.
    Wang, Y.
    Lin, M.
    Li, H.
    Qiu, Y.
    Hong, M.
    Zhou, G.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2013, 17 (01) : 17 - 25
  • [8] CYP2E1 RsaI/PstI polymorphism and risk of anti-tuberculosis drug-induced liver injury: a meta-analysis
    Deng, R.
    Yang, T.
    Wang, Y.
    Tang, N.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2012, 16 (12) : 1574 - 1581
  • [9] Transforming growth factor-beta 1 polymorphisms and anti-tuberculosis drug-induced liver injury. Polymorphisms in TGFβ1 and its relationship with anti-tuberculosis drug-induced liver injury
    Wu, Shouquan
    Wang, Yu
    Zhang, Miaomiao
    Wang, Minggui
    He, Jian-Qing
    THERAPIE, 2019, 74 (03): : 399 - 406
  • [10] The efficacy and safety of moxibustion for pressure injury A protocol for systematic review and meta-analysis
    Xiang, Wei
    Jiang, Jianmei
    Hu, Tingting
    Deng, Xiaoling
    Chen, Cheng
    Chen, Zhongrong
    MEDICINE, 2022, 101 (06)